7Baggers

DENTSPLY SIRONA Inc
(NASDAQ:XRAY) 

XRAY stock logo

DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instrument...

Founded: 1899
Full Time Employees: 15,200
Sector: Healthcare
Industry: Medical Instruments & Supplies

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 
                                                             
      net sales
    880,000,000 961,000,000 904,000,000 936,000,000 879,000,000 905,000,000 951,000,000 984,000,000 953,000,000 1,012,000,000 947,000,000 1,028,000,000 978,000,000 983,000,000 947,000,000 1,023,000,000 969,000,000 1,088,000,000 1,069,000,000 1,067,000,000 1,027,000,000 1,082,300,000 894,800,000 490,600,000 874,300,000 1,111,500,000 962,100,000 1,009,400,000 946,200,000 1,059,700,000 928,400,000 1,042,100,000 956,100,000 1,091,000,000 1,009,200,000 992,700,000 900,500,000 996,500,000 954,200,000 1,022,000,000 772,600,000 671,100,000 648,900,000 698,006,000 656,320,000 719,041,000 708,240,000 765,225,000 730,114,000 753,658,000 704,018,000 761,010,000 732,084,000 753,288,000 695,734,000 762,994,000 716,413,000 
      yoy
    0.11% 6.19% -4.94% -4.88% -7.76% -10.57% 0.42% -4.28% -2.56% 2.95% 0.00% 0.49% 0.93% -9.65% -11.41% -4.12% -5.65% 0.53% 19.47% 117.49% 17.47% -2.63% -7.00% -51.40% -7.60% 4.89% 3.63% -3.14% -1.04% -2.87% -8.01% 4.98% 6.17% 9.48% 5.76% -2.87% 16.55% 48.49% 47.05% 46.42% 17.72% -6.67% -8.38% -8.78% -10.11% -4.59% 0.60% 0.55% -0.27% 0.05% 1.19% -0.26% 2.19%     
      qoq
    -8.43% 6.31% -3.42% 6.48% -2.87% -4.84% -3.35% 3.25% -5.83% 6.86% -7.88% 5.11% -0.51% 3.80% -7.43% 5.57% -10.94% 1.78% 0.19% 3.89% -5.11% 20.95% 82.39% -43.89% -21.34% 15.53% -4.69% 6.68% -10.71% 14.14% -10.91% 8.99% -12.36% 8.11% 1.66% 10.24% -9.63% 4.43% -6.63% 32.28% 15.12% 3.42% -7.04% 6.35% -8.72% 1.53% -7.45% 4.81% -3.12% 7.05% -7.49% 3.95% -2.81% 8.27% -8.82% 6.50%  
      cost of products sold
    453,000,000 518,000,000 463,000,000 446,000,000 413,000,000 459,000,000 456,000,000 473,000,000 447,000,000 490,000,000 452,000,000 478,000,000 459,000,000 466,000,000 439,000,000 442,000,000 448,000,000 495,000,000 478,000,000 469,000,000 448,000,000 511,500,000 452,500,000 314,500,000 406,500,000 500,900,000 448,100,000 468,600,000 446,500,000 534,900,000 452,300,000 489,300,000 442,000,000 497,700,000 450,200,000 448,500,000 408,500,000 455,000,000 440,600,000 495,100,000 353,700,000 296,400,000 279,400,000 298,345,000 282,952,000 325,990,000 320,176,000 340,756,000 335,909,000 355,819,000 327,601,000 346,054,000 343,884,000 252,701,750 331,619,000 355,525,000 323,663,000 
      gross profit
    427,000,000 443,000,000 441,000,000 490,000,000 466,000,000 446,000,000 495,000,000 511,000,000 506,000,000 522,000,000 495,000,000 550,000,000 519,000,000 517,000,000 508,000,000 581,000,000 521,000,000 593,000,000 591,000,000 598,000,000 579,000,000 570,800,000 442,300,000 176,100,000 467,800,000 610,600,000 514,000,000 540,800,000 499,700,000 524,800,000 476,100,000 552,800,000 514,100,000 593,300,000 559,000,000 544,200,000 492,000,000 541,500,000 513,600,000 526,900,000 418,900,000 374,700,000 369,500,000 399,661,000 373,368,000 393,051,000 388,064,000 424,469,000 394,205,000 397,839,000 376,417,000 414,956,000 388,200,000 392,053,000 364,115,000 407,469,000 392,750,000 
      yoy
    -8.37% -0.67% -10.91% -4.11% -7.91% -14.56% 0.00% -7.09% -2.50% 0.97% -2.56% -5.34% -0.38% -12.82% -14.04% -2.84% -10.02% 3.89% 33.62% 239.58% 23.77% -6.52% -13.95% -67.44% -6.38% 16.35% 7.96% -2.17% -2.80% -11.55% -14.83% 1.58% 4.49% 9.57% 8.84% 3.28% 17.45% 44.52% 39.00% 31.84% 12.19% -4.67% -4.78% -5.84% -5.29% -1.20% 3.09% 2.29% 1.55% 1.48% 3.38% 1.84% -1.16%     
      qoq
    -3.61% 0.45% -10.00% 5.15% 4.48% -9.90% -3.13% 0.99% -3.07% 5.45% -10.00% 5.97% 0.39% 1.77% -12.56% 11.52% -12.14% 0.34% -1.17% 3.28% 1.44% 29.05% 151.16% -62.36% -23.39% 18.79% -4.96% 8.22% -4.78% 10.23% -13.87% 7.53% -13.35% 6.14% 2.72% 10.61% -9.14% 5.43% -2.52% 25.78% 11.80% 1.41% -7.55% 7.04% -5.01% 1.29% -8.58% 7.68% -0.91% 5.69% -9.29% 6.89% -0.98% 7.67% -10.64% 3.75%  
      gross margin %
    48.52% 46.10% 48.78% 52.35% 53.01% 49.28% 52.05% 51.93% 53.10% 51.58% 52.27% 53.50% 53.07% 52.59% 53.64% 56.79% 53.77% 54.50% 55.29% 56.04% 56.38% 52.74% 49.43% 35.89% 53.51% 54.93% 53.42% 53.58% 52.81% 49.52% 51.28% 53.05% 53.77% 54.38% 55.39% 54.82% 54.64% 54.34% 53.83% 51.56% 54.22% 55.83% 56.94% 57.26% 56.89% 54.66% 54.79% 55.47% 53.99% 52.79% 53.47% 54.53% 53.03% 52.05% 52.34% 53.40% 54.82% 
      selling, general, and administrative expenses
    351,000,000 383,000,000 355,000,000 342,000,000 358,000,000 401,000,000 390,000,000 399,000,000 415,000,000 409,000,000 372,000,000 416,000,000 416,000,000 402,000,000 401,000,000 410,000,000 376,000,000 294,250,000 394,000,000 398,000,000 385,000,000 253,625,000 341,900,000 279,100,000 393,500,000 315,525,000 399,300,000 430,900,000                              
      research and development expenses
    44,000,000 40,000,000 37,000,000 37,000,000 36,000,000 42,000,000 40,000,000 41,000,000 42,000,000 43,000,000 46,000,000 49,000,000 46,000,000 43,000,000 41,000,000 45,000,000 45,000,000 59,000,000 35,000,000 40,000,000 37,000,000                                     
      restructuring and other costs
    67,000,000 4,500,000 5,000,000 4,000,000 9,000,000 11,250,000 23,000,000 21,000,000 1,000,000 -3,000,000 6,000,000 5,000,000 59,000,000   7,000,000 3,000,000 6,000,000 3,000,000 5,000,000 3,000,000 14,500,000 18,700,000 1,300,000 42,500,000 12,600,000 5,200,000 42,400,000 20,500,000 9,800,000 12,100,000 188,900,000 10,200,000 319,800,000 20,600,000 81,700,000 3,100,000 7,600,000 7,900,000 3,600,000 4,100,000 13,800,000 6,600,000 38,881,000 5,426,000 6,545,000 2,503,000 1,242,000 793,000 8,291,000 2,231,000 2,169,000 665,000 6,855,000 15,097,000 2,528,000 1,237,000 
      operating income
    -35,000,000 -139,000,000 -218,000,000 -128,000,000 63,000,000 -509,000,000 -462,000,000 50,000,000 42,000,000 73,000,000 -236,000,000 80,000,000 -2,000,000 65,000,000 -1,218,000,000 119,000,000 97,000,000 154,000,000 159,000,000 155,000,000 154,000,000 135,400,000 81,700,000 -104,300,000 -124,800,000 136,600,000 109,500,000 67,500,000 47,300,000 81,800,000 45,500,000 -1,154,100,000 68,700,000 -706,400,000 107,900,000 -1,048,000,000 84,200,000 134,200,000 126,600,000 121,200,000 72,700,000 93,100,000 98,600,000 85,801,000 97,709,000 103,343,000 109,581,000 127,106,000 105,570,000 97,421,000 105,021,000 122,866,000 93,858,000 97,207,000 88,666,000 108,907,000 87,160,000 
      yoy
    -155.56% -72.69% -52.81% -356.00% 50.00% -797.26% 95.76% -37.50% -2200.00% 12.31% -80.62% -32.77% -102.06% -57.79% -866.04% -23.23% -37.01% 13.74% 94.61% -248.61% -223.40% -0.88% -25.39% -254.52% -363.85% 66.99% 140.66% -105.85% -31.15% -111.58% -57.83% 10.12% -18.41% -626.38% -14.77% -964.69% 15.82% 44.15% 28.40% 41.26% -25.60% -9.91% -10.02% -32.50% -7.45% 6.08% 4.34% 3.45% 12.48% 0.22% 18.45% 12.82% 7.68%     
      qoq
    -74.82% -36.24% 70.31% -303.17% -112.38% 10.17% -1024.00% 19.05% -42.47% -130.93% -395.00% -4100.00% -103.08% -105.34% -1123.53% 22.68% -37.01% -3.14% 2.58% 0.65% 13.74% 65.73% -178.33% -16.43% -191.36% 24.75% 62.22% 42.71% -42.18% 79.78% -103.94% -1779.91% -109.73% -754.68% -110.30% -1344.66% -37.26% 6.00% 4.46% 66.71% -21.91% -5.58% 14.92% -12.19% -5.45% -5.69% -13.79% 20.40% 8.36% -7.24% -14.52% 30.91% -3.45% 9.63% -18.59% 24.95%  
      operating margin %
    -3.98% -14.46% -24.12% -13.68% 7.17% -56.24% -48.58% 5.08% 4.41% 7.21% -24.92% 7.78% -0.20% 6.61% -128.62% 11.63% 10.01% 14.15% 14.87% 14.53% 15.00% 12.51% 9.13% -21.26% -14.27% 12.29% 11.38% 6.69% 5.00% 7.72% 4.90% -110.75% 7.19% -64.75% 10.69% -105.57% 9.35% 13.47% 13.27% 11.86% 9.41% 13.87% 15.19% 12.29% 14.89% 14.37% 15.47% 16.61% 14.46% 12.93% 14.92% 16.15% 12.82% 12.90% 12.74% 14.27% 12.17% 
      other income and expenses:
                                                             
      interest expense
    24,000,000 22,000,000 23,000,000 24,000,000 19,000,000 16,000,000 18,000,000 17,000,000 18,000,000 23,000,000 18,000,000 21,000,000 19,000,000 19,000,000 14,000,000 15,000,000 12,000,000 12,000,000 13,000,000 16,000,000 14,000,000 14,500,000 14,500,000 12,300,000 6,700,000 6,400,000 6,600,000 8,000,000 8,400,000 9,400,000 9,700,000 9,600,000 8,600,000 9,600,000 9,800,000 9,600,000 9,300,000 9,000,000 8,400,000 9,300,000 9,200,000 25,800,000 9,600,000 9,824,000 10,668,000 11,492,000 12,665,000 11,798,000 10,955,000 11,455,000 11,442,000 11,507,000 15,221,000 11,213,500 14,488,000 14,584,000 15,782,000 
      other expense
    -17,000,000   1,000,000  -2,000,000 -2,000,000 -1,000,000 -7,000,000 -7,000,000 -4,000,000 13,000,000 7,000,000 38,000,000 9,000,000   4,000,000 8,000,000 5,000,000 -9,000,000 -2,800,000 900,000 4,300,000 -1,400,000 -6,900,000 -2,900,000 12,100,000 -13,800,000 -4,500,000 4,700,000 -1,000,000 -34,100,000 1,925,000 900,000 7,800,000 -1,000,000 -6,800,000 1,600,000   -900,000 -3,800,000 -376,000 609,000        2,918,000     
      income before income taxes
    -42,000,000 -147,000,000 -230,000,000 -153,000,000 44,000,000 -523,000,000 -478,000,000 34,000,000 31,000,000 57,000,000 -250,000,000 46,000,000 -28,000,000 8,000,000 -1,241,000,000 91,000,000 87,000,000 138,000,000 138,000,000 134,000,000 149,000,000 122,900,000 66,700,000 -119,900,000 -129,700,000 137,500,000 106,500,000 47,600,000 53,800,000 77,400,000 31,700,000 -1,162,300,000 94,800,000 -712,900,000 97,600,000 -1,064,800,000 76,600,000 132,600,000 117,100,000 123,800,000 67,400,000 72,300,000 93,200,000 77,013,000 87,174,000 94,718,000 97,516,000 116,477,000 95,662,000 87,927,000 94,136,000 109,379,000 77,894,000 86,120,000 75,781,000 95,586,000 73,191,000 
      provision for income taxes
    -32,000,000 -2,000,000 198,000,000 -109,000,000 25,000,000 17,250,000 17,000,000 38,000,000 14,000,000 -15,000,000 16,000,000 -39,000,000 -5,000,000 23,000,000 -164,000,000 18,000,000 18,000,000 36,000,000 35,000,000 35,000,000 32,000,000 24,300,000 12,500,000 -24,000,000 10,200,000 35,000,000 21,500,000 11,200,000 14,600,000 75,900,000 4,200,000 -41,300,000 13,700,000 2,375,000 7,100,000 -14,500,000 16,900,000 24,700,000 24,800,000   15,800,000 19,600,000 24,775,000 18,853,000        3,542,000     
      net income
    -10,000,000 -145,000,000 -428,000,000 -44,000,000 19,000,000 -428,000,000 -495,000,000 -4,000,000 17,000,000 72,000,000 -266,000,000 85,000,000 -23,000,000 -15,000,000 -1,077,000,000 73,000,000 69,000,000 102,000,000 103,000,000 99,000,000 117,000,000 98,600,000 54,200,000 -95,900,000 -139,900,000 102,500,000 85,000,000 36,400,000 39,200,000 1,500,000 27,500,000 -1,121,000,000 81,100,000 -650,200,000 90,500,000 -1,050,300,000 59,700,000 107,900,000 92,300,000 105,900,000 125,300,000 58,600,000 84,400,000 44,064,000 63,954,000 84,713,000 75,266,000 90,014,000 72,920,000 76,032,000 80,866,000 88,691,000 72,573,000 127,928,000 54,292,000 82,040,000 54,228,000 
      yoy
    -152.63% -66.12% -13.54% 1000.00% 11.76% -694.44% 86.09% -104.71% -173.91% -580.00% -75.30% 16.44% -133.33% -114.71% -1145.63% -26.26% -41.03% 3.45% 90.04% -203.23% -183.63% -3.80% -36.24% -363.46% -456.89% 6733.33% 209.09% -103.25% -51.66% -100.23% -69.61% 6.73% 35.85% -702.59% -1.95% -1091.78% -52.35% 84.13% 9.36% 140.33% 95.92% -30.83% 12.14% -51.05% -12.30% 11.42% -6.93% 1.49% 0.48% -40.57% 48.95% 8.11% 33.83%     
      qoq
    -93.10% -66.12% 872.73% -331.58% -104.44% -13.54% 12275.00% -123.53% -76.39% -127.07% -412.94% -469.57% 53.33% -98.61% -1575.34% 5.80% -32.35% -0.97% 4.04% -15.38% 18.66% 81.92% -156.52% -31.45% -236.49% 20.59% 133.52% -7.14% 2513.33% -94.55% -102.45% -1482.24% -112.47% -818.45% -108.62% -1859.30% -44.67% 16.90% -12.84% -15.48% 113.82% -30.57% 91.54% -31.10% -24.51% 12.55% -16.38% 23.44% -4.09% -5.98% -8.82% 22.21% -43.27% 135.63% -33.82% 51.29%  
      net income margin %
    -1.14% -15.09% -47.35% -4.70% 2.16% -47.29% -52.05% -0.41% 1.78% 7.11% -28.09% 8.27% -2.35% -1.53% -113.73% 7.14% 7.12% 9.38% 9.64% 9.28% 11.39% 9.11% 6.06% -19.55% -16.00% 9.22% 8.83% 3.61% 4.14% 0.14% 2.96% -107.57% 8.48% -59.60% 8.97% -105.80% 6.63% 10.83% 9.67% 10.36% 16.22% 8.73% 13.01% 6.31% 9.74% 11.78% 10.63% 11.76% 9.99% 10.09% 11.49% 11.65% 9.91% 16.98% 7.80% 10.75% 7.57% 
      less: net loss attributable to noncontrolling interest
     -250,000 -1,000,000      -1,000,000 -1,250,000  -1,000,000 -4,000,000           -500,000                                  
      net income attributable to dentsply sirona
    -10,000,000   -45,000,000 20,000,000   -4,000,000 18,000,000   86,000,000 -19,000,000 -15,000,000 -1,077,000,000 73,000,000 69,000,000 102,000,000 103,000,000 99,000,000 117,000,000 98,500,000 53,800,000 -95,400,000 -139,900,000 102,300,000 85,000,000 36,400,000 39,200,000 1,800,000 28,000,000  81,200,000 -650,400,000 90,600,000 -1,050,000,000 59,800,000 107,000,000 92,500,000 105,400,000 125,000,000                 
      earnings per common share attributable to dentsply sirona:
                                                             
      basic
    -50,000   -220,000 100,000   -20,000                             260,000 460,000 400,000 450,000 720,000 410,000 600,000 320 460 600 530 630 510 530 560 610 500 900 380 570 380 
      diluted
    -50,000   -220,000 100,000   -20,000                             260,000 460,000 390,000 440,000 700,000 410,000 590,000 310 450 590 520 620 500 510 550 600 490 880 370 560 370 
      weighted-average common shares outstanding:
                                                             
      basic
    199,900,000 199,400,000 199,500,000 199,300,000 199,100,000 203,200,000 201,000,000 205,600,000 207,400,000 212,000,000 211,800,000 211,900,000 214,500,000 215,500,000 214,900,000 214,900,000 217,000,000 218,400,000 218,600,000 218,400,000 218,800,000 219,200,000 218,500,000 218,700,000 220,900,000 223,100,000 223,100,000 224,200,000 223,300,000 224,300,000 222,400,000 225,200,000 227,200,000 229,400,000 229,500,000 229,400,000 230,100,000 218,000,000 232,600,000 233,700,000 174,800,000 140,000,000 139,800,000 139,813,000 140,296,000 141,714,000 141,766,000 141,790,000 142,053,000 142,663,000 142,421,000 142,922,000 142,775,000 141,850,000 141,843,000 141,737,000 141,721,000 
      diluted
    199,900,000 199,400,000 199,500,000 199,300,000 199,800,000 203,200,000 201,000,000 205,600,000 208,500,000 212,000,000 211,800,000 213,100,000 214,500,000 215,500,000 214,900,000 215,300,000 217,800,000 220,200,000 220,500,000 220,700,000 219,900,000 219,200,000 219,200,000 218,700,000 220,900,000 224,400,000 224,900,000 225,700,000 225,000,000 224,300,000 223,700,000 225,200,000 229,900,000 229,400,000 233,100,000 229,400,000 234,000,000 221,600,000 236,300,000 237,400,000 178,400,000 142,500,000 142,400,000 142,262,000 142,804,000 144,219,000 144,286,000 144,164,000 144,453,000 144,965,000 144,698,000 145,133,000 145,099,000 143,945,000 143,884,000 143,863,000 143,984,000 
      goodwill and intangible asset impairments
     153,000,000 262,000,000 235,000,000  504,000,000 504,000,000    307,000,000                                               
      other income
     -2,500,000 -11,000,000                                     -11,500,000 -3,400,000     -1,845,000 791,000 575,000 388,000 -394,000 1,581,000 4,223,000  492,250 739,000 748,000 484,000 
      net loss attributable to dentsply sirona
     -146,000,000 -427,000,000   -430,000,000 -494,000,000   -49,750,000 -266,000,000                     -1,122,000,000                          
      loss per common share attributable to dentsply sirona:
                                                             
      basic
     -567,500 -2,140,000   -587,500 -2,460,000                                                   
      diluted
     -567,500 -2,140,000   -587,500 -2,460,000                                                   
      less: net income attributable to noncontrolling interest
       1,000,000                  -25,000 400,000       100,000 -500,000                           
      intangible asset impairments
            6,000,000                                                 
      less: net loss attributable to noncontrolling interests
        -1,000,000 -500,000 -1,000,000                          -100,000                         
      net income per common share attributable to dentsply sirona:
                                                             
      basic
            90,000   410,000 -90,000 -70,000 -5,010,000 340,000 320,000 470,000 470,000 450,000 530,000 450,000 250,000 -440,000 -630,000 460,000 380,000 160,000 180,000 -10,000 130,000  360,000 -2,840,000 390,000 -4,580,000                      
      diluted
            90,000   400,000 -90,000 -70,000 -5,010,000 340,000 320,000 460,000 470,000 450,000 530,000 450,000 250,000 -440,000 -630,000 460,000 380,000 160,000 170,000 -10,000 130,000  350,000 -2,840,000 390,000 -4,580,000                      
      net loss per common share attributable to dentsply sirona:
                                                             
      basic
             -235,000 -1,250,000                     -4,980,000                          
      diluted
             -235,000 -1,250,000                     -4,980,000                          
      goodwill impairment
                  1,187,000,000       400,000   156,600,000       1,085,800,000  558,000,000  1,092,900,000                      
      intangible asset impairment and other costs
                 7,000,000 97,000,000                                           
      other expense (income)
                   13,000,000 -2,000,000                                         
      interest income
                         800,000 -400,000 -1,000,000 -400,000 -400,000 -700,000 -200,000 -1,100,000 -500,000 -600,000 -400,000 -600,000 -700,000 -400,000 -600,000 -700,000 -600,000 -500,000 -400,000 -500,000 -400,000 -400,000 -660,000 -742,000 -1,022,000 -1,391,000 -1,744,000 -1,435,000 -1,567,000 -2,138,000 -2,243,000 -2,175,000 54,741,000 -2,342,000 -2,011,000 -2,297,000 
      selling, general and administrative expenses
                                431,900,000 433,200,000 418,500,000 432,200,000 435,200,000 421,900,000 430,500,000 417,600,000 404,700,000 399,700,000 379,100,000 402,100,000 342,100,000 267,800,000 264,300,000 274,979,000 270,233,000 283,163,000 275,980,000 296,121,000 287,842,000 292,127,000 269,165,000 289,921,000 293,677,000 215,185,000 260,352,000 296,034,000 304,353,000 
      net income per common share attributable to dentsply sirona
                                                             
      basic
            90,000   410,000 -90,000 -70,000 -5,010,000 340,000 320,000 470,000 470,000 450,000 530,000 450,000 250,000 -440,000 -630,000 460,000 380,000 160,000 180,000 -10,000 130,000  360,000 -2,840,000 390,000 -4,580,000                      
      diluted
            90,000   400,000 -90,000 -70,000 -5,010,000 340,000 320,000 460,000 470,000 450,000 530,000 450,000 250,000 -440,000 -630,000 460,000 380,000 160,000 170,000 -10,000 130,000  350,000 -2,840,000 390,000 -4,580,000                      
      less: net income attributable to noncontrolling interests
                                   1,000,000  200,000 -100,000 -300,000 -100,000 900,000 -200,000 500,000 300,000  -100,000 -35,000 -7,000 3,000 -7,000 21,000 42,000 1,603,000 1,015,000 1,463,000 888,000 787,000 928,000 1,276,000 944,000 
      dividends declared per common share:
                                   87,500 87,500 87,500 87,500 87,500                      
      equity in net income of unconsolidated affiliated company
                                             -425,000 10,800,000   -406,000 -967,000 -367,000 -290,000        -4,248,000 
      earnings per common share:
                                                             
      basic
    -50,000   -220,000 100,000   -20,000                             260,000 460,000 400,000 450,000 720,000 410,000 600,000 320 460 600 530 630 510 530 560 610 500 900 380 570 380 
      diluted
    -50,000   -220,000 100,000   -20,000                             260,000 460,000 390,000 440,000 700,000 410,000 590,000 310 450 590 520 620 500 510 550 600 490 880 370 560 370 
      benefit for income taxes
                                           17,900,000 -57,900,000                 
      net income attributable to dentsply international
                                             58,600,000 84,500,000 44,099,000 63,961,000 84,710,000 75,273,000 89,993,000 72,878,000 74,429,000 79,851,000 87,228,000 71,685,000 126,800,000 53,364,000 80,764,000 53,284,000 
      equity in net loss of unconsolidated affiliated company
                                               -8,174,000 -4,367,000        -1,779,000     
      benefit from income taxes
                                                 11,289,000 21,283,000 26,096,000 22,452,000 12,551,000 13,187,000 22,870,000  12,137,500 18,960,000 14,875,000 14,715,000 
      equity in net earnings of unconsolidated affiliated company
                                                     80,000 -83,000 2,182,000  -1,362,000 -2,529,000 1,329,000  
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-06-30 2012-03-31 
                                                           
        assets
                                                           
        current assets:
                                                           
        cash and cash equivalents
      190,000,000 326,000,000 363,000,000 359,000,000 398,000,000 272,000,000 296,000,000 279,000,000 291,000,000 334,000,000 309,000,000 295,000,000 318,000,000 365,000,000 418,000,000 362,000,000 374,000,000 339,000,000 281,000,000 332,000,000 318,000,000 438,000,000 1,272,000,000 1,109,100,000 235,900,000 404,900,000 226,100,000 250,100,000 225,400,000 309,600,000 233,100,000 239,300,000 317,100,000 320,600,000 370,000,000 268,400,000 363,300,000 383,900,000 330,700,000 311,600,000 323,100,000 284,600,000 236,400,000 96,472,000 100,619,000 97,652,000 66,929,000 55,823,000 50,658,000 57,027,000 56,203,000 53,210,000 67,346,000 
        accounts and notes receivable
      622,000,000 688,000,000 654,000,000 646,000,000 604,000,000 556,000,000 671,000,000 591,000,000 656,000,000 695,000,000 649,000,000 670,000,000 652,000,000 632,000,000 645,000,000 661,000,000 707,000,000 747,000,000 748,000,000 678,000,000 643,000,000 673,000,000 628,100,000 500,200,000 709,100,000 782,000,000 698,400,000 700,100,000 658,500,000 701,900,000 702,000,000 710,300,000 670,400,000 746,200,000 734,400,000 664,200,000 598,600,000 636,000,000 672,100,000 637,200,000 625,200,000 399,900,000 429,800,000 447,500,000 409,865,000 476,856,000 503,972,000 496,221,000 502,370,000 499,006,000 468,537,000 462,233,000 461,352,000 
        inventories
      659,000,000 642,000,000 686,000,000 675,000,000 612,000,000 564,000,000 619,000,000 608,000,000 613,000,000 624,000,000 651,000,000 657,000,000 659,000,000 627,000,000 592,000,000 581,000,000 553,000,000 504,000,000 532,000,000 539,000,000 500,000,000 466,000,000 489,100,000 548,900,000 590,500,000 561,700,000 605,100,000 608,300,000 618,200,000 598,900,000 672,000,000 666,300,000 696,600,000 623,100,000 624,400,000 596,800,000 565,100,000 517,100,000 556,400,000 523,100,000 562,100,000 340,400,000 361,300,000 374,820,000 380,098,000 422,485,000 461,203,000 455,074,000 448,277,000 433,189,000 417,094,000 403,195,000 403,052,000 
        prepaid expenses and other current assets
      374,000,000 367,000,000 369,000,000 286,000,000 364,000,000 354,000,000 335,000,000 280,000,000 342,000,000 320,000,000 304,000,000 298,000,000 314,000,000 269,000,000 284,000,000 281,000,000 263,000,000 247,000,000 243,000,000 236,000,000 235,000,000 214,000,000 190,400,000 204,700,000 269,700,000 251,300,000 281,700,000 269,800,000 293,500,000 277,600,000 295,700,000 276,500,000 316,400,000 312,600,000 243,600,000 236,300,000 193,600,000 345,600,000 282,400,000 266,500,000 295,100,000 171,800,000 180,600,000 351,538,000 309,500,000 260,708,000 199,170,000 195,205,000 151,840,000 180,811,000 218,685,000 186,544,000 187,435,000 
        total current assets
      1,845,000,000 2,023,000,000 2,072,000,000 1,966,000,000 1,978,000,000 1,746,000,000 1,921,000,000 1,758,000,000 1,902,000,000 1,973,000,000 1,913,000,000 1,920,000,000 1,943,000,000 1,893,000,000 1,939,000,000 1,885,000,000 1,897,000,000 1,837,000,000 1,804,000,000 1,785,000,000 1,696,000,000 1,791,000,000 2,579,600,000 2,362,900,000 1,805,200,000 1,999,900,000 1,811,300,000 1,828,300,000 1,795,600,000 1,888,000,000 1,902,800,000 1,892,400,000 2,000,500,000 2,002,500,000 1,972,400,000 1,765,700,000 1,720,600,000 1,882,600,000 1,841,600,000 1,738,400,000 1,805,500,000 1,196,700,000 1,208,100,000 1,270,330,000 1,200,082,000 1,257,701,000 1,231,274,000 1,202,323,000 1,153,145,000 1,170,033,000 1,160,519,000 1,105,182,000 1,119,185,000 
        property, plant, and equipment
      858,000,000  841,000,000 840,000,000 791,000,000  817,000,000 789,000,000 782,000,000  753,000,000 772,000,000 770,000,000  714,000,000 744,000,000 771,000,000  771,000,000 769,000,000 758,000,000      782,500,000 819,600,000                          
        operating lease right-of-use assets
      139,000,000 139,000,000 131,000,000 139,000,000 133,000,000 136,000,000 150,000,000 162,000,000 171,000,000 178,000,000 182,000,000 191,000,000 191,000,000 200,000,000 201,000,000 205,000,000 204,000,000 193,000,000 183,000,000 184,000,000 168,000,000 176,000,000 144,100,000 138,800,000 146,900,000 159,300,000 156,700,000 155,800,000 163,900,000                         
        identifiable intangible assets
      924,000,000 974,000,000 1,065,000,000 1,133,000,000 1,212,000,000 1,207,000,000 1,538,000,000 1,559,000,000 1,618,000,000 1,705,000,000 1,711,000,000 1,808,000,000 1,862,000,000 1,903,000,000 1,875,000,000 2,100,000,000 2,228,000,000 2,319,000,000 2,402,000,000 2,488,000,000 2,461,000,000 2,504,000,000 2,058,100,000 2,039,600,000 2,045,400,000 2,176,300,000 2,167,700,000 2,295,900,000 2,324,700,000 2,420,300,000 2,488,000,000 2,546,800,000 2,811,400,000 2,800,700,000 3,109,200,000 3,059,400,000 2,955,100,000 2,957,600,000 3,135,600,000 3,028,500,000 3,138,100,000 600,700,000 600,400,000 616,669,000 613,457,000 710,112,000 765,105,000 785,997,000 800,470,000 786,667,000 805,646,000 947,747,000 998,538,000 
        goodwill
      1,142,000,000 1,148,000,000 1,270,000,000 1,528,000,000 1,632,000,000 1,597,000,000 1,937,000,000 2,389,000,000 2,400,000,000 2,438,000,000 2,374,000,000 2,703,000,000 2,701,000,000 2,688,000,000 2,584,000,000 3,858,000,000 3,944,000,000 3,976,000,000 4,000,000,000 4,033,000,000 3,952,000,000 3,986,000,000 3,282,700,000 3,227,200,000 3,191,800,000 3,396,500,000 3,355,700,000 3,412,700,000 3,399,200,000 3,431,300,000 3,443,600,000 3,457,800,000 4,573,200,000 4,539,200,000 5,074,900,000 5,023,600,000 5,958,200,000 5,952,000,000 6,056,700,000 5,794,700,000 5,836,000,000 1,987,600,000 1,984,300,000 1,998,608,000 1,953,271,000 2,160,696,000 2,278,798,000 2,286,715,000 2,218,136,000 2,158,529,000 2,167,241,000 2,036,084,000 2,109,451,000 
        other noncurrent assets
      321,000,000 284,000,000 274,000,000 463,000,000 304,000,000 301,000,000 263,000,000 240,000,000 250,000,000 276,000,000 268,000,000 256,000,000 206,000,000 198,000,000 209,000,000 156,000,000 128,000,000 122,000,000 128,000,000 119,000,000 102,000,000 94,000,000 59,000,000 64,000,000 92,500,000 68,500,000 92,900,000 63,000,000 67,200,000 76,800,000 69,100,000 67,400,000 99,500,000 156,100,000 182,600,000 160,300,000 153,000,000 64,100,000 95,600,000 95,700,000 86,300,000 59,100,000 54,200,000 43,113,000 61,254,000 148,628,000 157,984,000 172,080,000 209,719,000 154,426,000 159,872,000 194,458,000 183,727,000 
        total assets
      5,229,000,000 5,429,000,000 5,653,000,000 6,069,000,000 6,050,000,000 5,753,000,000 6,626,000,000 6,897,000,000 7,123,000,000 7,370,000,000 7,201,000,000 7,650,000,000 7,673,000,000 7,643,000,000 7,522,000,000 8,948,000,000 9,172,000,000 9,220,000,000 9,288,000,000 9,378,000,000 9,137,000,000 9,342,000,000 8,895,900,000 8,604,200,000 8,058,400,000 8,602,900,000 8,366,800,000 8,575,300,000 8,604,500,000 8,687,000,000 8,769,200,000 8,822,000,000 10,372,800,000 10,374,500,000 11,199,000,000 10,850,000,000 11,594,000,000 11,656,100,000 11,952,400,000 11,451,400,000 11,682,400,000 4,402,900,000 4,402,200,000 4,496,756,000 4,384,830,000 4,884,061,000 5,072,373,000 5,089,433,000 5,009,979,000 4,874,683,000 4,902,128,000 4,870,756,000 5,015,061,000 
        liabilities and equity
                                                           
        current liabilities:
                                                           
        accounts payable
      259,000,000 300,000,000 268,000,000 268,000,000 276,000,000 241,000,000 297,000,000 287,000,000 279,000,000 305,000,000 262,000,000 265,000,000 267,000,000 279,000,000 271,000,000 289,000,000 277,000,000 268,000,000 276,000,000 281,000,000 283,000,000 305,000,000 242,800,000 214,100,000 271,100,000 307,900,000 246,300,000 248,100,000 269,000,000 283,900,000 287,800,000 292,400,000 286,800,000 284,400,000 249,000,000 245,600,000 258,400,000 223,000,000 224,000,000 227,100,000 287,400,000 133,600,000 137,500,000 132,966,000 134,090,000 128,233,000 143,562,000 141,591,000 136,945,000 147,455,000 148,715,000 145,850,000 163,419,000 
        accrued liabilities
      688,000,000 700,000,000 712,000,000 672,000,000 738,000,000 754,000,000 798,000,000 650,000,000 681,000,000 749,000,000 732,000,000 728,000,000 748,000,000 727,000,000 711,000,000 688,000,000 694,000,000 679,000,000 641,000,000 621,000,000 557,000,000 653,000,000 564,100,000 486,900,000 522,900,000 629,200,000 541,000,000 524,400,000 511,100,000 578,900,000 568,500,000 575,300,000 531,700,000 585,800,000 538,300,000 455,100,000 424,300,000 462,700,000 482,800,000 466,100,000 500,200,000 310,100,000 309,100,000 296,280,000 240,040,000 443,516,000 412,849,000 398,881,000 335,745,000 308,148,000 347,397,000 347,906,000 323,845,000 
        income taxes payable
      30,000,000 30,000,000 47,000,000 42,000,000 37,000,000 45,000,000 25,000,000 24,000,000 27,000,000 49,000,000 37,000,000 17,000,000 43,000,000 46,000,000 68,000,000 44,000,000 54,000,000 57,000,000 58,000,000 44,000,000 44,000,000 60,000,000 75,200,000 61,700,000 64,500,000 56,100,000 69,900,000 52,000,000 69,800,000 58,100,000 69,000,000 31,900,000 54,300,000 54,200,000 39,700,000 31,400,000 42,100,000 64,200,000 47,000,000 19,500,000 55,700,000 20,200,000 33,600,000 64,023,000 40,072,000 47,567,000 38,604,000 23,829,000 33,923,000 17,947,000 14,615,000 12,646,000 19,182,000 
        notes payable and current portion of long-term debt
      230,000,000 313,000,000 378,000,000 184,000,000 742,000,000 549,000,000 422,000,000 362,000,000 343,000,000 322,000,000 187,000,000 261,000,000 316,000,000 118,000,000 246,000,000 220,000,000 347,000,000 182,000,000 151,000,000 305,000,000 328,000,000 299,000,000 296,100,000 300,000 33,000,000 2,300,000 11,700,000 56,300,000 20,700,000 92,400,000 154,800,000 218,100,000 22,600,000 30,100,000 21,400,000 21,600,000 22,700,000 21,100,000 16,400,000 9,800,000 10,900,000 12,100,000 453,200,000 119,704,000 247,631,000 115,253,000 301,294,000 403,145,000 270,948,000 417,065,000 315,438,000 241,801,000 288,037,000 
        total current liabilities
      1,207,000,000 1,343,000,000 1,405,000,000 1,166,000,000 1,793,000,000 1,589,000,000 1,542,000,000 1,323,000,000 1,330,000,000 1,425,000,000 1,218,000,000 1,271,000,000 1,374,000,000 1,170,000,000 1,296,000,000 1,241,000,000 1,372,000,000 1,186,000,000 1,126,000,000 1,251,000,000 1,212,000,000 1,317,000,000 1,178,200,000 763,000,000 891,500,000 995,500,000 868,900,000 880,800,000 870,600,000 1,013,300,000 1,080,100,000 1,117,700,000 895,400,000 954,500,000 848,400,000 753,700,000 747,500,000 771,000,000 770,200,000 722,500,000 854,200,000 476,000,000 933,400,000 612,973,000 661,833,000 734,569,000 896,309,000 967,446,000 777,561,000 890,615,000 826,165,000 748,203,000 794,483,000 
        long-term debt
      2,006,000,000 2,015,000,000 2,017,000,000 2,218,000,000 1,593,000,000 1,586,000,000 1,795,000,000 1,737,000,000 1,747,000,000 1,796,000,000 1,803,000,000 1,841,000,000 1,842,000,000 1,826,000,000 1,737,000,000 1,807,000,000 1,872,000,000 1,913,000,000 1,925,000,000 1,946,000,000 1,923,000,000 1,978,000,000 1,930,000,000 2,182,700,000 1,421,200,000 1,433,100,000 1,403,900,000 1,441,300,000 1,545,100,000 1,564,900,000 1,574,800,000 1,586,600,000 1,645,500,000 1,611,600,000 1,600,700,000 1,587,300,000 1,528,100,000 1,511,100,000 1,569,800,000 1,171,800,000 1,169,100,000 1,141,000,000 701,900,000 1,077,779,000 1,078,823,000 1,165,566,000 1,065,881,000 1,065,463,000 1,164,794,000 1,123,792,000 1,207,722,000 1,482,783,000 1,481,217,000 
        operating lease liabilities
      95,000,000 93,000,000 85,000,000 92,000,000 88,000,000 91,000,000 103,000,000 113,000,000 120,000,000 125,000,000 133,000,000 144,000,000 144,000,000 149,000,000 154,000,000 159,000,000 157,000,000 145,000,000 139,000,000 139,000,000 125,000,000 130,000,000 105,400,000 101,000,000 108,300,000 119,500,000 118,500,000 119,300,000 125,500,000                         
        deferred income taxes
      84,000,000 94,000,000 95,000,000 109,000,000 134,000,000 129,000,000 193,000,000 194,000,000 214,000,000 228,000,000 249,000,000 261,000,000 271,000,000 287,000,000 246,000,000 409,000,000 389,000,000 408,000,000 413,000,000 415,000,000 411,000,000 393,000,000 423,100,000 439,200,000 464,700,000 479,600,000 500,700,000 519,800,000 535,100,000 552,800,000 513,700,000 538,000,000 641,400,000 718,000,000 818,200,000 802,400,000 753,200,000 848,600,000 854,500,000 849,800,000 875,500,000 160,300,000 152,900,000 155,587,000 150,470,000 215,482,000 231,005,000 236,269,000 226,668,000 218,624,000 226,100,000 334,673,000 321,362,000 
        other noncurrent liabilities
      518,000,000 544,000,000 573,000,000 523,000,000 432,000,000 415,000,000 503,000,000 466,000,000 454,000,000 502,000,000 427,000,000 431,000,000 404,000,000 399,000,000 475,000,000 494,000,000 518,000,000 525,000,000 560,000,000 550,000,000 536,000,000 554,000,000 496,900,000 472,900,000 482,500,000 480,300,000 415,700,000 431,200,000 418,700,000 423,000,000 446,300,000 439,600,000 485,300,000 462,500,000 441,900,000 432,400,000 401,600,000 399,500,000 400,800,000 391,700,000 398,200,000 286,200,000 332,500,000 334,128,000 319,452,000 272,200,000 294,404,000 295,657,000 361,938,000 353,556,000 372,747,000 316,098,000 371,024,000 
        total liabilities
      3,910,000,000 4,089,000,000 4,175,000,000 4,108,000,000 4,040,000,000 3,810,000,000 4,136,000,000 3,833,000,000 3,865,000,000 4,076,000,000 3,830,000,000 3,948,000,000 4,035,000,000 3,831,000,000 3,908,000,000 4,110,000,000 4,308,000,000 4,177,000,000 4,163,000,000 4,301,000,000 4,207,000,000 4,372,000,000 4,133,600,000 3,958,800,000 3,368,200,000 3,508,000,000 3,307,700,000 3,392,400,000 3,495,000,000 3,554,000,000 3,614,900,000 3,681,900,000 3,667,600,000 3,746,600,000 3,709,200,000 3,575,800,000 3,430,400,000 3,530,200,000 3,595,300,000 3,135,800,000 3,297,000,000 2,063,500,000 2,120,700,000 2,180,467,000 2,210,578,000 2,387,817,000 2,487,599,000 2,564,835,000 2,530,961,000 2,586,587,000 2,632,734,000 2,881,757,000 2,968,086,000 
        commitments and contingencies
                                                           
        equity:
                                                           
        preferred stock, 1.00 par value; 0.25 million shares authorized; no shares issued
                                                           
        common stock, 0.01 par value...
      3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 3,000,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000                     
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2026 and december 31, 2025
                                                           
        200.3 million and 199.6 million shares outstanding at march 31, 2026 and december 31, 2025
                                                           
        capital in excess of par value
      6,616,000,000 6,644,000,000 6,638,000,000 6,638,000,000 6,631,000,000 6,640,000,000 6,639,000,000 6,631,000,000 6,639,000,000 6,643,000,000 6,645,000,000 6,648,000,000 6,604,000,000 6,629,000,000 6,619,000,000 6,617,000,000 6,573,000,000 6,606,000,000 6,659,000,000 6,638,000,000 6,618,000,000 6,604,000,000 6,592,400,000 6,576,700,000 6,553,900,000 6,586,700,000 6,567,200,000 6,551,300,000 6,520,400,000 6,522,300,000 6,528,700,000 6,526,200,000 6,531,700,000 6,543,900,000 6,544,900,000 6,527,400,000 6,516,200,000 6,516,700,000 6,509,300,000 6,498,800,000 6,489,700,000 237,800,000 232,000,000 225,002,000 211,114,000 227,027,000 217,274,000 211,467,000 250,153,000 244,598,000 238,945,000 230,862,000 224,841,000 
        accumulated deficit
      -1,574,000,000 -1,564,000,000 -1,385,000,000 -925,000,000 -848,000,000                                                 
        accumulated other comprehensive loss
      -655,000,000 -639,000,000 -672,000,000 -641,000,000 -659,000,000 -730,000,000 -638,000,000 -677,000,000 -666,000,000 -636,000,000 -657,000,000 -620,000,000 -614,000,000 -628,000,000 -844,000,000 -719,000,000 -629,000,000 -592,000,000 -567,000,000 -511,000,000 -554,000,000 -464,000,000 -577,600,000 -644,700,000 -712,200,000 -599,700,000 -609,100,000 -502,600,000 -537,400,000 -478,700,000 -466,500,000 -440,800,000 -281,000,000 -291,000,000 -318,600,000 -438,000,000 -658,000,000 -705,700,000 -479,400,000 -514,600,000 -431,200,000 -594,000,000 -587,500,000 -475,006,000 -573,567,000 -253,055,000 -97,999,000 -75,665,000 -120,104,000 -223,222,000 -199,101,000 -203,712,000 -68,031,000 
        treasury stock
      -3,072,000,000 -3,105,000,000 -3,106,000,000 -3,115,000,000 -3,117,000,000 -3,136,000,000 -3,139,000,000 -3,045,000,000 -2,908,000,000 -2,922,000,000 -2,783,000,000 -2,788,000,000 -2,759,000,000 -2,649,000,000 -2,663,000,000 -2,666,000,000 -2,640,000,000 -2,535,000,000 -2,454,000,000 -2,458,000,000 -2,468,000,000 -2,409,000,000 -2,413,100,000 -2,416,200,000 -2,399,000,000 -2,301,300,000 -2,227,700,000 -2,132,000,000 -2,122,900,000 -2,151,000,000 -2,166,400,000 -2,177,000,000 -1,936,100,000 -1,955,400,000 -1,737,100,000 -1,745,100,000 -1,695,000,000 -1,647,300,000 -1,547,400,000 -1,460,000,000 -1,376,800,000 -898,400,000 -908,700,000 -905,118,000 -900,866,000 -785,940,000 -777,081,000 -773,520,000 -723,488,000 -732,210,000 -689,096,000 -731,253,000 -730,955,000 
        total dentsply sirona equity
      1,318,000,000 1,339,000,000 1,478,000,000 1,960,000,000 2,010,000,000 1,942,000,000 2,491,000,000 3,064,000,000 3,258,000,000 3,293,000,000 3,375,000,000 3,706,000,000 3,641,000,000 3,811,000,000 3,613,000,000 4,837,000,000 4,863,000,000 5,042,000,000 5,122,000,000 5,074,000,000 4,927,000,000 4,967,000,000 4,760,500,000 4,643,100,000 4,687,500,000 5,092,500,000 5,057,300,000 5,181,100,000 5,107,700,000 5,121,100,000 5,142,000,000 5,127,200,000 6,693,100,000 6,616,300,000 7,477,800,000 7,262,500,000 8,152,200,000 8,114,300,000 8,344,100,000 8,311,500,000 8,381,800,000             
        noncontrolling interests
      1,000,000 1,000,000  1,000,000  1,000,000 -1,000,000   1,000,000 -4,000,000 -4,000,000 -3,000,000 1,000,000 1,000,000 1,000,000 1,000,000 1,000,000 3,000,000 3,000,000 3,000,000 3,000,000 1,800,000 2,300,000 2,700,000 2,400,000 1,800,000 1,800,000 1,800,000 11,900,000 12,300,000 12,900,000 12,100,000 11,600,000 12,000,000 11,700,000 11,400,000 11,600,000 13,000,000 4,100,000 3,600,000 1,400,000 1,400,000 1,419,000 1,459,000 1,136,000 1,311,000 1,565,000 40,577,000 37,911,000 35,892,000 37,430,000 38,358,000 
        total equity
      1,319,000,000 1,340,000,000 1,478,000,000 1,961,000,000 2,010,000,000 1,943,000,000 2,490,000,000 3,064,000,000 3,258,000,000 3,294,000,000 3,371,000,000 3,702,000,000 3,638,000,000 3,812,000,000 3,614,000,000 4,838,000,000 4,864,000,000 5,043,000,000 5,125,000,000 5,077,000,000 4,930,000,000 4,970,000,000 4,762,300,000 4,645,400,000 4,690,200,000 5,094,900,000 5,059,100,000 5,182,900,000 5,109,500,000 5,133,000,000 5,154,300,000 5,140,100,000 6,705,200,000 6,627,900,000 7,489,800,000 7,274,200,000 8,163,600,000 8,125,900,000 8,357,100,000 8,315,600,000 8,385,400,000 2,339,400,000 2,281,500,000 2,316,289,000 2,174,252,000 2,496,244,000 2,584,774,000 2,524,598,000 2,479,018,000 2,288,096,000 2,269,394,000 1,988,999,000 2,046,975,000 
        total liabilities and equity
      5,229,000,000 5,429,000,000 5,653,000,000 6,069,000,000 6,050,000,000 5,753,000,000 6,626,000,000 6,897,000,000 7,123,000,000 7,370,000,000 7,201,000,000 7,650,000,000 7,673,000,000 7,643,000,000 7,522,000,000 8,948,000,000 9,172,000,000 9,220,000,000 9,288,000,000 9,378,000,000 9,137,000,000 9,342,000,000 8,895,900,000 8,604,200,000 8,058,400,000 8,602,900,000 8,366,800,000 8,575,300,000 8,604,500,000 8,687,000,000 8,769,200,000 8,822,000,000 10,372,800,000 10,374,500,000 11,199,000,000 10,850,000,000 11,594,000,000 11,656,100,000 11,952,400,000 11,451,400,000 11,682,400,000 4,402,900,000 4,402,200,000 4,496,756,000 4,384,830,000 4,884,061,000 5,072,373,000 5,089,433,000 5,009,979,000 4,874,683,000 4,902,128,000 4,870,756,000 5,015,061,000 
        property, plant and equipment
       861,000,000    766,000,000    800,000,000    761,000,000    773,000,000    791,000,000 772,400,000 771,700,000 776,600,000 802,400,000   853,900,000 870,600,000 865,700,000 857,600,000 888,200,000 876,000,000 859,900,000 841,000,000 807,100,000 799,800,000 822,900,000 794,100,000 816,500,000 558,800,000 555,200,000 568,036,000 556,766,000 606,924,000 639,212,000 642,318,000 628,509,000 605,028,000 608,850,000 587,285,000 604,160,000 
        400.0 million shares authorized at december 31, 2025 and 2024
                                                           
        264.5 million shares issued at december 31, 2025 and 2024
                                                           
        199.6 million and 198.8 million shares outstanding at december 31, 2025 and 2024, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2025 and december 31, 2024
                                                           
        199.5 million and 198.8 million shares outstanding at september 30, 2025 and december 31, 2024
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2025 and december 31, 2024
                                                           
        199.3 million and 198.8 million shares outstanding at june 30, 2025 and december 31, 2024
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2025 and december 31, 2024
                                                           
        199.3 million and 198.8 million shares outstanding at march 31, 2025 and december 31, 2024
                                                           
        400.0 million shares authorized at december 31, 2024 and 2023
                                                           
        264.5 million shares issued at december 31, 2024 and 2023
                                                           
        198.8 million and 207.2 million shares outstanding at december 31, 2024 and 2023, respectively
                                                           
        (accumulated deficit) retained earnings
           -835,000,000 -374,000,000                                               
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2024 and december 31, 2023
                                                           
        198.8 million and 207.2 million shares outstanding at september 30, 2024 and december 31, 2023
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2024 and december 31, 2023
                                                           
        202.6 million and 207.2 million shares outstanding at june 30, 2024 and december 31, 2023
                                                           
        retained earnings
             152,000,000 190,000,000 205,000,000 167,000,000 463,000,000 407,000,000 456,000,000 498,000,000 1,602,000,000 1,556,000,000 1,560,000,000 1,481,000,000 1,402,000,000 1,328,000,000 1,233,000,000 1,156,200,000 1,124,700,000 1,242,200,000 1,404,200,000 1,324,300,000 1,261,800,000 1,245,000,000 1,225,900,000 1,243,600,000 1,216,200,000 2,375,900,000 2,316,200,000 2,986,000,000 2,915,600,000 3,986,400,000 3,948,000,000 3,859,000,000 3,784,700,000 3,697,500,000 3,591,000,000 3,542,700,000 3,468,364,000 3,434,484,000 3,305,448,000 3,239,641,000 3,159,123,000 3,030,252,000 2,959,391,000 2,881,126,000 2,654,044,000 2,581,134,000 
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2024 and december 31, 2023
                                                           
        207.6 million and 207.2 million shares outstanding at march 31, 2024 and december 31, 2023
                                                           
        400.0 million shares authorized at december 31, 2023 and 2022
                                                           
        264.5 million shares issued at december 31, 2023 and 2022
                                                           
        207.2 million and 215.2 million shares outstanding at december 31, 2023 and 2022, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2023 and december 31, 2022
                                                           
        211.8 million and 215.3 million shares outstanding at september 30, 2023 and december 31, 2022
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2023 and december 31, 2022
                                                           
        211.7 million and 215.3 million shares outstanding at june 30, 2023 and december 31, 2022
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2023 and december 31, 2022
                                                           
        212.5 million and 215.3 million shares outstanding at march 31, 2023 and december 31, 2022
                                                           
        400.0 million shares authorized at december 31, 2022 and 2021
                                                           
        264.5 million shares issued at december 31, 2022 and 2021
                                                           
        215.3 million and 217.4 million shares outstanding at december 31, 2022 and 2021, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2022 and december 31, 2021
                                                           
        214.9 million and 217.4 million shares outstanding at september 30, 2022 and december 31, 2021
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2022 and december 31, 2021
                                                           
        214.8 million and 217.4 million shares outstanding at june 30, 2022 and december 31, 2021
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2022 and december 31, 2021
                                                           
        215.5 million and 217.4 million shares outstanding at march 31, 2022 and december 31, 2021
                                                           
        400.0 million shares authorized at december 31, 2021 and 2020
                                                           
        264.5 million shares issued at december 31, 2021 and 2020
                                                           
        217.4 million and 218.7 million shares outstanding at december 31, 2021 and 2020, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2021 and december 31, 2020
                                                           
        218.6 million and 218.7 million shares outstanding at september 30, 2021 and december 31, 2020
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2021 and december 31, 2020
                                                           
        218.5 million and 218.7 million shares outstanding at june 30, 2021 and december 31, 2020
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2021 and december 31, 2020
                                                           
        218.2 million and 218.7 million shares outstanding at march 31, 2021 and december 31, 2020, respectively
                                                           
        400.0 million shares authorized at december 31, 2020 and 2019
                                                           
        264.5 million shares issued at december 31, 2020 and 2019
                                                           
        218.7 million and 221.3 million shares outstanding at december 31, 2020 and 2019, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at september 30, 2020 and december 31, 2019
                                                           
        218.5 million and 221.3 million shares outstanding at september 30, 2020 and december 31, 2019, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at june 30, 2020 and december 31, 2019
                                                           
        218.4 million and 221.3 million shares outstanding at june 30, 2020 and december 31, 2019, respectively
                                                           
        400.0 million shares authorized, and 264.5 million shares issued at march 31, 2020 and december 31, 2019
                                                           
        219.1 million and 221.3 million shares outstanding at march 31, 2020 and december 31, 2019, respectively
                                                           
        400.0 million shares authorized at december 31, 2019 and 2018
                                                           
        264.5 million shares issued at december 31, 2019 and 2018
                                                           
        221.3 million and 223.0 million shares outstanding at december 31, 2019 and 2018, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at september 30, 2019 and december 31, 2018
                                                           
        222.3 million and 223.0 million shares outstanding at september 30, 2019 and december 31, 2018, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at june 30, 2019 and december 31, 2018, respectively
                                                           
        224.1 million and 223.0 million shares outstanding at june 30, 2019 and december 31, 2018, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at march 31, 2019 and december 31, 2018, respectively
                                                           
        223.8 million and 223.0 million shares outstanding at march 31, 2019 and december 31, 2018, respectively
                                                           
        400.0 million shares authorized at december 31, 2018 and 2017
                                                           
        264.5 million shares issued at december 31, 2018 and 2017
                                                           
        223.0 million and 226.8 million shares outstanding at december 31, 2018 and 2017, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at september 30, 2018 and december 31, 2017, respectively
                                                           
        222.5 million and 226.8 million shares outstanding at september 30, 2018 and december 31, 2017, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at june 30, 2018 and december 31, 2017, respectively
                                                           
        222.2 million and 226.8 million shares outstanding at june 30, 2018 and december 31, 2017, respectively
                                                           
        400.0 million shares authorized and 264.5 million shares issued at march 31, 2018 and december 31, 2017, respectively
                                                           
        227.4 million and 226.8 million shares outstanding at march 31, 2018 and december 31, 2017, respectively
                                                           
        preferred stock, 1.00 par value; .25 million shares authorized; no shares issued
                                                           
        common stock, .01 par value...
                                       2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 2,600,000 1,600,000 1,600,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 1,628,000 
        400.0 million shares authorized at december 31, 2017 and 2016
                                                           
        264.5 million shares issued at december 31, 2017 and 2016
                                                           
        226.8 million and 230.1 million shares outstanding at december 31, 2017 and 2016, respectively
                                                           
        400.0 million shares authorized at september 30, 2017 and december 31, 2016, respectively
                                                           
        264.5 million shares issued at september 30, 2017 and december 31, 2016, respectively
                                                           
        229.6 million and 230.1 million shares outstanding at september 30, 2017 and december 31, 2016, respectively
                                                           
        400.0 million shares authorized at june 30, 2017 and december 31, 2016, respectively
                                                           
        264.5 million shares issued at june 30, 2017 and december 31, 2016, respectively
                                                           
        229.3 million and 230.1 million shares outstanding at june 30, 2017 and december 31, 2016, respectively
                                                           
        400.0 million shares authorized at march 31, 2017 and december 31, 2016, respectively
                                                           
        264.5 million shares issued at march 31, 2017 and december 31, 2016, respectively
                                                           
        229.9 million and 230.1 million shares outstanding at march 31, 2017 and december 31, 2016, respectively
                                                           
        400.0 million and 200.0 million shares authorized at december 31, 2016 and 2015, respectively
                                                           
        264.5 million and 162.8 million shares issued at december 31, 2016 and 2015, respectively
                                                           
        230.1 million and 140.1 million shares outstanding at december 31, 2016 and 2015, respectively
                                                           
        preferred stock, 1.00 par value; 0.3 million shares authorized; no shares issued
                                                           
        400.0 million and 200.0 million shares authorized at september 30, 2016 and december 31, 2015, respectively
                                                           
        264.5 million and 162.8 million shares issued at september 30, 2016 and december 31, 2015, respectively
                                                           
        231.6 million and 140.1 million shares outstanding at september 30, 2016 and december 31, 2015, respectively.
                                                           
        400.0 million and 200.0 million shares authorized at june 30, 2016 and december 31, 2015, respectively
                                                           
        264.5 million and 162.8 million shares issued at june 30, 2016 and december 31, 2015, respectively
                                                           
        233.0 million and 140.1 million shares outstanding at june 30, 2016 and december 31, 2015, respectively.
                                                           
        400.0 million and 200.0 million shares authorized at march 31, 2016 and december 31, 2015, respectively
                                                           
        264.5 million and 162.8 million shares issued at march 31, 2016 and december 31, 2015, respectively
                                                           
        234.2 million and 140.1 million shares outstanding at march 31, 2016 and december 31, 2015, respectively.
                                                           
        total dentsply international equity
                                               2,338,000,000 2,280,100,000 2,314,870,000 2,172,793,000 2,495,108,000 2,583,463,000 2,523,033,000 2,438,441,000 2,250,185,000 2,233,502,000 1,951,569,000 2,008,617,000 
        preferred stock, .01 par value...
                                                           
        cash flows from operating activities:
                                                           
        net income
                                                      242,129,000 161,264,000  136,269,000 54,228,000 
        adjustments to reconcile net income to net cash from operating activities:
                                                           
        depreciation
                                                      61,545,000 41,743,000  40,357,000 20,209,000 
        amortization
                                                      34,700,000 23,434,000  28,014,000 15,364,000 
        amortization of deferred financing costs
                                                      3,842,000 2,592,000  2,391,000 1,196,000 
        share-based compensation expense
                                                      18,027,000 12,023,000  11,029,000 4,222,000 
        restructuring and other costs - noncash
                                                      843,000 1,570,000  2,105,000 1,165,000 
        stock option income tax benefit
                                                      -2,262,000 -1,122,000  -5,163,000 -3,879,000 
        equity in (earnings) income from unconsolidated affiliates
                                                      -320,000 -403,000    
        other non-cash income
                                                      3,422,000 11,480,000    
        changes in operating assets and liabilities, net of acquisitions:
                                                           
        income taxes
                                                      29,544,000 -17,670,000    
        net cash from operating activities
                                                      258,266,000 131,868,000  103,395,000 19,953,000 
        cash flows from investing activities:
                                                           
        capital expenditures
                                                      -73,500,000 -46,151,000  -42,986,000 -18,642,000 
        cash paid for acquisitions of businesses, net of cash acquired
                                                      -3,939,000 -3,939,000    
        cash received on derivatives
                                                      9,172,000 7,499,000    
        cash paid on derivatives
                                                      -95,667,000 -94,843,000    
        expenditures for identifiable intangible assets
                                                      -1,049,000 -963,000  -188,000 -146,000 
        purchase of company-owned life insurance policies
                                                         -1,577,000 -1,577,000 
        proceeds from sale of property, plant and equipment
                                                      3,092,000 2,209,000  465,000 166,000 
        net cash from investing activities
                                                      -161,891,000 -136,188,000  -58,507,000 -20,199,000 
        cash flows from financing activities:
                                                           
        net change in short-term borrowings
                                                      8,789,000 40,450,000  -35,181,000 11,155,000 
        cash paid for treasury stock
                                                      -72,381,000 -62,278,000  -38,840,000 -30,869,000 
        cash dividends paid
                                                      -25,895,000 -16,928,000  -15,706,000 -7,847,000 
        cash paid for contingent consideration on prior acquisitions
                                                         -1,781,000 -1,781,000 
        cash paid for acquisition of noncontrolling interests of consolidated subsidiary
                                                      -8,960,000 -8,960,000    
        proceeds from long-term borrowings
                                                      174,628,000    4,571,000 
        repayments of long-term borrowings
                                                      -251,335,000    -5,171,000 
        proceeds from exercise of stock options
                                                      48,350,000 31,213,000  20,066,000 14,483,000 
        excess tax benefits from share-based compensation
                                                      2,262,000 1,122,000  5,163,000 3,879,000 
        cash received on derivative contracts
                                                      21,000 25,000    
        cash paid on derivative contracts
                                                      -129,000 -80,000    
        net cash from financing activities
                                                      -124,650,000 -15,436,000  -67,414,000 -12,380,000 
        effect of exchange rate changes on cash and cash equivalents
                                                      -1,199,000 -3,349,000  -1,392,000 2,844,000 
        net decrease in cash and cash equivalents
                                                      -29,474,000 -23,105,000    
        cash and cash equivalents at beginning of period
                                                      80,132,000 80,132,000  77,128,000 77,128,000 
        cash and cash equivalents at end of period
                                                      50,658,000 57,027,000  53,210,000 67,346,000 
        net interest expense on derivatives with an other-than-insignificant financing element
                                                         1,135,000 800,000 
        equity in earnings from unconsolidated affiliates
                                                         2,919,000 4,248,000 
        other non-cash expense
                                                         -4,237,000 1,079,000 
        payments on settlements of net investment hedges
                                                         -14,221,000  
        cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
                                                           
        payment on terminated derivative instruments
                                                           
        net interest payments on derivatives with an other-than-insignificant financing element
                                                         -1,135,000 -800,000 
        net increase in cash and cash equivalents
                                                         -23,918,000 -9,782,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-09-30 2014-06-30 2014-03-31 2013-09-30 2013-06-30 2013-03-31 2012-06-30 2012-03-31 
                                                             
          cash flows from operating activities:
                                                             
          net income
        -10,000,000   -44,000,000 19,000,000   -4,000,000 17,000,000   85,000,000 -23,000,000 -15,000,000 -1,077,000,000 73,000,000 69,000,000 102,000,000 103,000,000 99,000,000 117,000,000 98,600,000 54,200,000 -95,900,000 -139,900,000 102,500,000 85,000,000 36,400,000 39,200,000    81,100,000 -650,200,000 90,500,000 -1,050,300,000 59,700,000 107,900,000 92,300,000 105,900,000 125,300,000 58,600,000 84,481,000 44,065,000 63,954,000 75,266,000 90,014,000 72,920,000 80,865,000 88,691,000 72,573,000 82,041,000 54,228,000 
          adjustments to reconcile net loss to net cash from operating activities:
                                                             
          depreciation
        38,000,000 37,000,000 36,000,000 34,000,000 34,000,000 34,000,000 35,000,000 32,000,000 32,000,000 33,000,000 35,000,000 33,000,000 31,000,000 29,000,000 31,000,000 30,000,000 29,000,000 30,000,000 30,000,000 32,000,000 32,000,000 38,200,000 39,300,000 32,300,000 32,200,000 31,600,000 31,200,000 35,500,000 34,900,000 29,500,000 34,600,000 35,500,000 33,300,000 33,400,000 31,800,000 31,200,000 30,900,000 29,600,000 31,900,000 31,600,000 23,500,000 17,500,000 22,818,000 19,471,000 19,311,000 20,723,000 20,955,000 21,370,000 19,802,000 21,327,000 20,416,000 20,148,000 20,209,000 
          amortization of intangible assets
        41,000,000 56,000,000 56,000,000 54,000,000 45,000,000 54,000,000 54,000,000 54,000,000 54,000,000 52,000,000 53,000,000 53,000,000 53,000,000 50,000,000 51,000,000 53,000,000 55,000,000 55,000,000 55,000,000 56,000,000 56,000,000 49,400,000 48,800,000 46,600,000 47,200,000 46,700,000 47,400,000 47,300,000 48,200,000 48,200,000 49,600,000 50,200,000 49,900,000 48,600,000 48,700,000 46,600,000 45,200,000                 
          deferred income taxes
        -60,000,000 -14,000,000 180,000,000 -137,000,000 1,000,000 -116,000,000 -9,000,000 -2,000,000 -9,000,000 -23,000,000 -24,000,000 -62,000,000 -21,000,000 -8,000,000 -207,000,000 1,000,000 -14,000,000 -9,000,000 -5,000,000 -3,000,000 -3,000,000 -11,300,000 -20,300,000 -24,300,000 -8,100,000 2,500,000 -21,500,000 -12,400,000 -6,000,000 35,900,000 -27,100,000 -54,000,000 -16,800,000 -97,500,000 -12,100,000 -44,000,000 9,800,000 -8,100,000 -31,500,000 9,900,000 -80,400,000 -11,800,000 10,503,000 8,525,000 20,172,000 9,528,000 6,612,000 -11,505,000 -23,532,000 3,229,000 -11,793,000 -8,122,000 3,690,000 
          stock-based compensation expense
        8,000,000 8,000,000 6,000,000 9,000,000 10,000,000 4,000,000                                                
          other non-cash expense
        -15,000,000 -23,000,000 -6,000,000 10,000,000 9,000,000 -45,000,000 -2,000,000 19,000,000 19,000,000 -34,000,000 -7,000,000 27,000,000 9,000,000 22,000,000 9,000,000 27,000,000 2,000,000 22,000,000 -8,000,000 3,000,000 17,000,000    8,100,000    -7,800,000   -16,900,000 14,000,000                -8,058,000 15,392,000 -3,912,000 -5,316,000 1,079,000 
          gain on disposal of assets
        -6,000,000                                                     
          changes in operating assets and liabilities:
                                                             
          accounts and notes receivable-trade
        60,000,000 -35,000,000 -25,000,000 -31,000,000 85,000,000 -67,000,000 59,000,000 27,000,000 -27,000,000 7,000,000 -23,000,000 -15,000,000 42,000,000 -10,000,000 19,000,000 34,000,000 -11,000,000 -81,000,000 -28,000,000 11,000,000 -23,100,000 -119,600,000 215,400,000 53,300,000 -70,700,000 -19,200,000 -38,000,000 36,500,000 -1,600,000 2,100,000 -64,500,000 87,500,000 -5,800,000 -59,500,000 -44,300,000 46,200,000 17,800,000 -10,100,000 -15,700,000 -67,100,000 27,000,000 12,097,000 -29,751,000 -10,246,000 589,000 -8,585,000 -22,920,000 6,869,000 -36,115,000 -36,209,000 -15,864,000 -25,597,000 
          inventories
        -23,000,000 44,000,000 -14,000,000 -21,000,000 -26,000,000 15,000,000 9,000,000 -2,000,000 -5,000,000 51,000,000 -13,000,000 -2,000,000 -30,000,000 -1,000,000 -45,000,000 -54,000,000 -41,000,000 19,000,000 -5,000,000 -27,000,000 -50,000,000 50,200,000 74,800,000 56,300,000 -57,300,000 62,100,000 -30,100,000 13,200,000 -31,500,000 63,400,000 -14,000,000 -4,600,000 -64,700,000 4,400,000 -17,700,000 -11,300,000 -38,300,000 24,500,000 -3,800,000 36,100,000 8,600,000 22,000,000 5,974,000 11,557,000 -7,431,000 16,674,000 -7,247,000 -15,180,000 -4,584,000 -18,620,000 -22,080,000 -13,028,000 -34,006,000 
          prepaid expenses and other current assets
        19,000,000 3,000,000 -36,000,000 27,000,000 -1,000,000 -23,000,000 32,000,000 57,000,000 -28,000,000 -6,000,000 -12,000,000 -23,000,000 -17,000,000 13,000,000 -7,000,000 -22,000,000 -17,000,000 -8,000,000 -5,000,000 5,000,000 -27,000,000 -8,200,000 17,200,000 60,200,000 -27,200,000 16,600,000 -11,500,000 24,200,000 -16,300,000 20,200,000 -21,600,000 -20,100,000 -5,600,000 -14,800,000 -900,000 -50,100,000 -9,200,000 -9,700,000 -14,200,000 8,400,000 -16,900,000 -2,500,000 -8,832,000 7,467,000 -5,635,000 -6,343,000 -317,000 -5,751,000 -227,000 22,279,000 4,085,000 4,617,000 -24,072,000 
          other noncurrent assets
        1,000,000   -3,000,000 4,000,000 1,000,000 -6,000,000 8,000,000 -3,000,000 -1,000,000 14,000,000 -7,000,000 -9,000,000 3,000,000 2,000,000 -4,000,000 5,000,000 -13,000,000 -7,000,000 2,100,000 12,700,000 -6,800,000 5,900,000 -21,300,000 2,100,000 4,800,000 -2,400,000 -2,600,000 -4,800,000 -2,900,000 -8,000,000 3,100,000 15,600,000 -14,400,000 -2,300,000 3,300,000 4,000,000 -2,400,000 -800,000 3,380,000 3,231,000 -2,511,000 -851,000 -369,000 1,465,000 147,000 1,443,000 -598,000 -19,451,000 15,954,000 
          accounts payable
        2,000,000 20,000,000 1,000,000 -24,000,000 14,000,000 -24,000,000 5,000,000 17,000,000 -28,000,000 24,000,000 5,000,000 -1,000,000 -14,000,000 -10,000,000 -9,000,000 30,000,000 19,000,000 -7,000,000 -11,000,000 -11,000,000 -17,000,000 41,700,000 24,000,000 -59,800,000 -28,900,000 56,600,000 1,700,000 -20,900,000 -11,300,000 -3,000,000 16,600,000 -2,600,000 -3,900,000 35,100,000 -400,000 -13,900,000 23,400,000 8,600,000 -15,300,000 12,700,000 1,200,000 -2,400,000 6,262,000 -309,000 5,247,000 -8,666,000 2,566,000 8,047,000 -13,956,000 -215,000 -10,928,000 -12,848,000 11,528,000 
          accrued liabilities
        -20,000,000 -8,000,000 -31,000,000 9,000,000 -44,000,000 -22,000,000 61,000,000 -28,000,000 -50,000,000 7,000,000 21,000,000 -13,000,000 -31,000,000 -4,000,000 45,000,000 6,000,000 -53,000,000 37,000,000 51,000,000 71,000,000 -81,000,000 55,600,000 66,000,000 -43,500,000 -95,100,000 80,800,000 45,600,000 9,000,000 -90,100,000 7,400,000 -2,500,000 72,800,000 -77,400,000 -18,500,000 66,000,000 16,800,000 -36,000,000 -14,700,000 13,600,000 4,400,000 -15,500,000 -9,300,000 22,278,000 18,580,000 -36,258,000 13,863,000 15,673,000 -21,901,000 4,327,000 3,938,000 -7,559,000 17,942,000 -21,186,000 
          income taxes
        7,000,000 13,000,000 10,000,000 -43,000,000 -12,000,000 53,000,000 -6,000,000 -7,000,000 -2,000,000 -5,000,000 28,000,000 3,000,000 -37,000,000 -56,000,000 39,000,000 -1,000,000 3,000,000 6,000,000 19,000,000 -8,000,000 -29,100,000 4,700,000 -21,600,000 7,000,000 -27,200,000 22,400,000 -23,300,000 12,300,000 -1,100,000 41,700,000 -14,400,000 -14,100,000 3,600,000 -8,700,000 16,000,000 -31,400,000 1,000,000 32,800,000 -40,400,000 -1,100,000 -900,000 -7,126,000 4,414,000 -4,488,000 -7,601,000 12,109,000 23,423,000 47,214,000 3,526,000 -21,196,000   
          other noncurrent liabilities
        -2,000,000 -1,000,000 69,000,000 -58,000,000 -15,000,000 -24,000,000 8,000,000 1,000,000 -13,000,000 -3,000,000 4,000,000 23,000,000 6,000,000 9,000,000 1,000,000 -2,000,000 -7,000,000 -10,000,000 12,000,000 -5,000,000 13,000,000 -1,400,000 -5,000,000 -5,800,000 -2,800,000 -6,800,000 2,800,000 1,500,000 300,000 -13,000,000 2,200,000 -10,700,000 5,000,000 1,900,000 -1,400,000 9,100,000 -1,400,000 -4,700,000 6,300,000 400,000 7,000,000 3,000,000 4,362,000 3,925,000 5,813,000 991,000 9,248,000 -1,716,000 795,000 -27,347,000 33,447,000 19,131,000 -15,535,000 
          net cash from operating activities
        40,000,000 101,000,000 79,000,000 48,000,000 7,000,000 87,000,000 141,000,000 208,000,000 25,000,000 160,000,000 134,000,000 104,000,000 -21,000,000 142,000,000 109,000,000 173,000,000 93,000,000 222,000,000 172,000,000 214,000,000 49,000,000 263,500,000 207,100,000 175,100,000 -10,700,000 299,300,000 159,100,000 145,100,000 29,300,000 202,200,000 125,600,000 116,900,000 55,100,000 228,900,000 164,300,000 126,200,000 82,500,000 222,400,000 152,900,000 187,400,000 700,000 126,400,000 159,755,000 145,614,000 65,631,000 147,535,000 155,680,000 64,565,000 126,398,000 95,782,000 36,086,000 83,442,000 19,953,000 
          cash flows from investing activities:
                                                             
          capital expenditures
        -52,000,000 -41,000,000 -39,000,000 -32,000,000 -19,000,000 -51,000,000 -43,000,000 -52,000,000 -34,000,000 -40,000,000 -37,000,000 -33,000,000 -39,000,000 -32,000,000 -32,000,000 -41,000,000 -44,000,000 -41,000,000 -35,000,000 -36,000,000 -30,000,000 -27,000,000 -21,200,000 -13,200,000 -25,600,000 -36,000,000 -23,400,000 -29,600,000 -33,900,000 -51,900,000 -49,400,000 -45,400,000 -35,800,000 -45,700,000 -33,800,000 -33,700,000 -31,100,000 -46,000,000 -31,200,000 -27,000,000 -20,800,000 -20,300,000 -18,266,000 -17,191,000 -16,243,000 -24,194,000 -23,509,000 -25,322,000 -27,349,000 -22,119,000 -24,032,000 -24,344,000 -18,642,000 
          free cash flows
        -12,000,000 60,000,000 40,000,000 16,000,000 -12,000,000 36,000,000 98,000,000 156,000,000 -9,000,000 120,000,000 97,000,000 71,000,000 -60,000,000 110,000,000 77,000,000 132,000,000 49,000,000 181,000,000 137,000,000 178,000,000 19,000,000 236,500,000 185,900,000 161,900,000 -36,300,000 263,300,000 135,700,000 115,500,000 -4,600,000 150,300,000 76,200,000 71,500,000 19,300,000 183,200,000 130,500,000 92,500,000 51,400,000 176,400,000 121,700,000 160,400,000 -20,100,000 106,100,000 141,489,000 128,423,000 49,388,000 123,341,000 132,171,000 39,243,000 99,049,000 73,663,000 12,054,000 59,098,000 1,311,000 
          net investment hedge settlements
        -7,000,000                                                     
          other investing activities
        6,000,000 1,000,000    -7,000,000     1,000,000                                       
          net cash from investing activities
        -53,000,000 -45,000,000 -36,000,000 -34,000,000 -17,000,000 -57,000,000 -47,000,000 -50,000,000 -43,000,000 -20,000,000 -2,000,000 -30,000,000 -37,000,000 -29,000,000 -26,000,000 -40,000,000 -43,000,000 -39,000,000 -40,000,000 -176,000,000 -103,000,000 -1,101,600,000 -23,800,000 34,900,000 -15,500,000 -28,700,000 -15,200,000 -11,800,000 -12,700,000 -48,300,000 -45,500,000 -114,300,000 -45,200,000 -50,600,000 -43,900,000 -150,800,000 -41,100,000 -46,600,000 -379,700,000 -18,100,000 504,400,000 -68,100,000 36,179,000 -14,432,000 -8,547,000 -21,059,000 -26,504,000 -28,842,000 -25,703,000 -63,465,000 -72,723,000 -38,308,000 -20,199,000 
          cash flows from financing activities:
                                                             
          proceeds from 364-day bridge loan
         435,000,000                                                 
          repayments on short-term borrowings
        -51,000,000                           -67,900,000                         
          cash dividends paid
        -32,000,000 -32,000,000 -32,000,000 -32,000,000 -32,000,000 -31,000,000 -33,000,000 -33,000,000 -29,000,000 -30,000,000 -29,000,000 -30,000,000 -27,000,000 -26,000,000 -27,000,000 -27,000,000 -24,000,000 -24,000,000 -24,000,000 -22,000,000 -22,000,000 -22,100,000 -21,900,000 -21,900,000 -22,100,000 -22,200,000 -19,600,000 -19,600,000 -19,500,000 -19,500,000 -19,400,000 -19,900,000 -19,800,000 -20,100,000 -20,100,000 -20,100,000 -18,000,000 -17,900,000 -18,100,000 -18,500,000 -10,100,000 -10,100,000 -10,260,000 -10,224,000 -9,416,000 -9,474,000 -9,474,000 -8,979,000 -8,967,000 -9,019,000 -7,909,000 -7,859,000 -7,847,000 
          repayments on long-term borrowings
        -31,000,000 -144,000,000 -1,000,000 -2,000,000 -80,000,000 -2,000,000 -3,000,000 -3,000,000 -1,000,000 -5,000,000   -2,000,000       -800,000 -116,600,000 -132,700,000 -1,900,000 -100,000 -8,900,000 -200,000 -200,000  -9,600,000 -1,200,000 -5,400,000  -375,700,000 -127,500,000  -8,868,000 -89,000 -100,143,000         
          cash paid for deferred financing costs
         -3,000,000 -10,000,000 -3,000,000                                                 
          other financing activities
        -5,000,000 -2,000,000 -1,000,000 -3,000,000 -6,000,000 -5,000,000 -5,000,000 -3,000,000 -2,000,000 -1,000,000 -4,000,000 -6,000,000 -7,000,000 -1,000,000 -7,000,000 -25,000,000 -3,000,000 -8,000,000                                 
          net cash from financing activities
        -119,000,000 -99,000,000 -36,000,000 -68,000,000 123,000,000 -38,000,000 -79,000,000 -171,000,000 -14,000,000 -128,000,000 -109,000,000 -87,000,000 17,000,000 -161,000,000 -6,000,000 -152,000,000 -10,000,000 -122,000,000 -179,000,000 -25,000,000 -53,000,000 -14,300,000 -23,900,000 658,100,000 -129,900,000 -95,800,000 -160,800,000 -110,300,000 -99,200,000 -78,600,000 -82,400,000 -69,400,000 -19,400,000 -232,200,000 -22,100,000 -78,900,000 -67,600,000 -112,700,000 237,100,000 -177,800,000 -472,800,000 -8,900,000 -55,490,000 -138,053,000 -100,457,000 -90,926,000 -117,968,000 -55,477,000 -109,214,000 -29,039,000 13,603,000 -55,034,000 -12,380,000 
          effect of exchange rate changes on cash and cash equivalents
        -4,000,000 6,000,000 -3,000,000 15,000,000 13,000,000 -16,000,000 2,000,000 1,000,000 -11,000,000 13,000,000 -9,000,000 -10,000,000 -6,000,000 -5,000,000 -21,000,000 7,000,000 -5,000,000 -3,000,000 -4,000,000 1,000,000 -13,000,000 18,300,000 3,500,000 5,100,000 -12,900,000 4,000,000 -7,100,000 1,700,000 -1,600,000 1,200,000 -3,900,000 -11,000,000 6,000,000 4,500,000 3,300,000 8,600,000 5,600,000 -9,900,000 8,800,000 -3,000,000 6,200,000 -1,200,000 -477,000 2,724,000 -7,647,000 -4,827,000 -102,000 623,000 2,150,000 -2,454,000 -895,000 -4,236,000 2,844,000 
          net increase in cash and cash equivalents
        -136,000,000 -37,000,000 4,000,000 -39,000,000 126,000,000     25,000,000 14,000,000 -23,000,000 -47,000,000 -53,000,000 56,000,000 -12,000,000 35,000,000 58,000,000 -51,000,000   -834,100,000 162,900,000           -49,400,000 101,600,000 -94,900,000 -20,600,000 53,200,000 19,100,000 -11,500,000 38,500,000 48,200,000          -14,136,000 -9,782,000 
          cash and cash equivalents at beginning of period
        326,000,000 272,000,000 334,000,000 365,000,000 339,000,000 438,000,000 100,000 404,900,000 309,600,000 320,600,000 383,900,000 284,600,000 -39,000 151,639,000 74,954,000 80,132,000 77,128,000 
          cash and cash equivalents at end of period
        190,000,000 -37,000,000 4,000,000 -39,000,000 398,000,000 -24,000,000 17,000,000 -12,000,000 291,000,000 25,000,000 14,000,000 -23,000,000 318,000,000 -53,000,000 56,000,000 -12,000,000 374,000,000 58,000,000 -51,000,000 14,000,000 318,000,000 -834,000,000 162,900,000 873,200,000 235,900,000 178,800,000 -24,000,000 24,700,000 225,400,000 76,500,000 -6,200,000 -77,800,000 317,100,000 -49,400,000 101,600,000 -94,900,000 363,300,000 53,200,000 19,100,000 -11,500,000 323,100,000 48,200,000 139,928,000 -4,147,000 100,619,000 30,723,000 11,106,000 55,823,000 -6,369,000 824,000 56,203,000 -14,136,000 67,346,000 
          supplemental disclosures of cash flow information:
                                                             
          interest paid, net of amounts capitalized
        44,000,000    13,000,000                                                 
          non-cash investing activities:
                                                             
          property, plant and equipment in accounts payable at end of period
        29,000,000  3,000,000 22,000,000                                                 
          exchange of inventory for naming and other rights
          14,000,000                                                 
          net loss
         -145,000,000    -428,000,000                         27,500,000                       
          goodwill impairment
                           400,000 156,600,000       558,000,000                   
          intangible asset impairment
                                                             
          loss on disposal of property, plant and equipment
                             300,000 100,000 400,000 200,000 700,000 2,300,000 700,000 -100,000 1,900,000 2,100,000 100,000 500,000 -700,000 1,900,000 100,000 300,000 1,000,000 1,300,000   200,000 119,000           
          cash received on sale of non-strategic businesses or product lines
                         1,000,000 8,000,000 19,000,000                               
          cash received on derivative contracts
         9,000,000 1,000,000     35,000,000 2,000,000 2,000,000 3,000,000 5,000,000 4,000,000 1,000,000 1,000,000    200,000 300,000                          -4,000     
          cash paid on derivative contracts
         -5,000,000 -7,000,000   -3,000,000 -9,000,000             -100,000 29,600,000                          -49,000     
          proceeds from long-term borrowings
         2,000,000 1,000,000                    100,000        200,000 100,000  -100,000 3,000,000  760,800,000 79,900,000            4,571,000 
          repayment of 364-day bridge loan
                                                           
          (repayments) proceeds on other short-term borrowings
         80,000,000 -3,000,000                                                   
          cash paid for treasury stock
             -100,000,000   -150,000,000 -150,000,000     -110,000,000 -90,000,000 -140,000,000 -100,000,000 -100,000,000     -250,000,000 100,000 -73,600,000 -77,900,000 -119,200,000 -94,700,000 -171,200,000 -428,800,000 -13,725,000 -13,966,000 -85,009,000 -16,171,000 -14,191,000 -40,395,000 -10,103,000   -7,971,000 -30,869,000 
          income taxes paid, net of refunds
                                                             
          change in accounts payable related to capital expenditures
                                                             
          exchange of inventory for naming rights
                                                             
          goodwill asset impairment
          253,000,000                                                   
          indefinite-lived intangible asset impairment
          9,000,000     6,000,000    6,000,000        300,000 38,700,000 5,300,000   266,900,000                   
          proceeds from sale of property, plant, and equipment
           1,000,000              1,000,000      700,000  3,600,000                           
          (repayments) proceeds on short-term borrowings
            -272,000,000                                                 
          equity in earnings from unconsolidated affiliates
                                                          1,779,000 -1,329,000 4,248,000 
          net borrowings on short-term borrowings
                                                             
          goodwill and intangible asset impairments
                                                             
          proceeds on short-term borrowings
              56,000,000 20,000,000 23,000,000  -75,000,000 -55,000,000 198,000,000  26,000,000 -125,000,000 163,000,000    30,000,000                                 
          net decrease in cash and cash equivalents
              17,000,000 -12,000,000 -43,000,000            -120,000,000    -169,000,000  -24,000,000 24,700,000 -84,200,000  -6,200,000 -77,800,000 -3,500,000           -4,147,000 -51,020,000  11,106,000 -19,131,000 -6,369,000 824,000 -23,929,000   
          adjustments to reconcile net income to net cash from operating activities:
                                                             
          stock based compensation expense
               12,000,000 11,000,000 13,000,000 2,000,000 14,000,000 17,000,000 12,000,000 14,000,000 22,000,000 11,000,000 -6,000,000 22,000,000 19,000,000 13,000,000 10,800,000 16,500,000 10,200,000 9,500,000 16,400,000 15,400,000 25,200,000 9,200,000 5,900,000 5,300,000 500,000 9,300,000 7,200,000 18,900,000 11,100,000 10,800,000                 
          changes in operating assets and liabilities, net of acquisitions:
                                                             
          fixed asset impairment
                    4,000,000         600,000    200,000                           
          restructuring and other costs
                 -6,000,000 -3,000,000 -6,000,000 48,000,000                                         
          loss on sale or disposal of non-strategic businesses and product lines
                                                             
          cash paid for acquisitions of businesses and equity investments, net of cash acquired
                         -7,000,000 -149,000,000 -92,000,000 -1,076,000,000    100,000    -123,800,000 -6,700,000                     
          proceeds from sale of property, plant and equipment
                             300,000      300,000 2,900,000 2,400,000 900,000 3,000,000 5,300,000 200,000 300,000 1,600,000 100,000 500,000 4,000,000 400,000 100,000 -3,000 212,000 91,000 324,000 109,000 168,000 883,000 991,000 1,218,000 299,000 166,000 
          net borrowings (repayments) on short-term borrowings
                                                             
          proceeds from exercised stock options
                     1,000,000 5,000,000 4,000,000 2,000,000 12,000,000 33,000,000 5,000,000 600,000 1,600,000 3,800,000 30,000,000 2,400,000 56,600,000 19,800,000  8,900,000 5,600,000 8,300,000  7,500,000 16,000,000 29,400,000  6,400,000 13,000,000 7,400,000  8,603,000 4,532,000 14,065,000 5,997,000        
          proceeds from long-term borrowings, net of deferred financing costs
                     -1,000,000 2,000,000 5,000,000 1,000,000 2,000,000 9,000,000 4,000,000     117,200,000 800,000 900,000                         
          payments on terminated derivative instruments
                                                             
          gain on sale of non-strategic businesses and product lines
                            -13,000,000                                 
          cash paid for accelerated share repurchase
                      -150,000,000                                     
          loss on sale on non-strategic businesses and product lines
                                                             
          loss on sale of non-strategic businesses and product lines
                          -1,000,000        -500,000                           
          proceeds (repayments) on short-term borrowings
                          141,000,000      30,800,000                             
          cash paid for acquisition of noncontrolling interest of consolidated subsidiary
                                                             
          deferred financing costs
                                                            
          amortization of deferred financing costs
                            2,000,000 1,600,000 1,600,000 1,100,000 700,000 600,000 700,000 700,000 700,000 700,000 700,000 600,000 700,000 700,000 600,000 600,000 700,000 900,000 1,500,000 1,000,000 1,100,000 8,000,000 1,123,000 1,088,000 1,089,000 1,232,000 1,143,000 1,142,000 1,250,000 1,296,000 1,296,000 1,195,000 1,196,000 
          definite-lived intangible asset impairment
                                                            
          restructuring and other costs - non-cash
                             4,200,000 1,300,000 2,600,000 1,900,000 900,000 400,000 5,100,000 9,700,000 3,300,000 10,100,000 5,800,000 3,300,000 53,100,000 10,600,000 400,000 600,000 5,500,000 900,000 700,000 2,600,000 5,500,000 -8,014,000 40,982,000 4,832,000         
          gain on sale of equity security
                                     -44,100,000                     
          gain on divestiture of noncontrolling interest
                                 -8,700,000                         
          purchases of short term investments
                                                             
          liquidation of short term investments
                                                             
          expenditures for identifiable intangible assets
                                     -200,000 -2,000,000 -3,300,000 -800,000 -1,100,000 -4,800,000       -178,000 2,000 -11,000 -1,305,000 -86,000 -758,000 -205,000 -42,000 -146,000 
          proceeds from the sale of equity security
                                                             
          cash paid for acquisition of noncontrolling interests of consolidated subsidiaries
                                                             
          cash paid for contingent consideration on prior acquisitions
                             -1,000,000 -300,000 -1,100,000 -1,600,000 -2,500,000 -100,000 -30,600,000                       -1,781,000 
          other non-cash income
                              -1,000,000   -7,900,000 4,300,000       11,500,000 -7,100,000 19,900,000 -14,400,000  -9,900,000 -28,100,000 -3,400,000 -3,100,000 3,725,000 -5,720,000 -8,005,000  -5,705,000 -3,405,000      
          repayments of long-term borrowings
                              -100,000                         -75,174,000     -5,171,000 
          purchase of short term investments
                                                             
          cash paid on sale of non-strategic businesses or product lines
                                                             
          cash received on derivatives contracts
                                9,400,000  7,500,000 4,300,000 22,700,000  1,800,000    1,200,000 2,900,000 2,400,000  2,000,000 5,000,000 5,700,000  8,133,000 5,674,000 8,593,000 3,197,000        
          purchase of short-term investments
                                   500,000 -800,000      -2,200,000 -100,000         -1,136,000 9,000 -1,144,000      
          purchase of company owned life insurance policies
                                                             
          net (repayments) borrowings on short-term borrowings
                                                             
          cash paid on derivatives contracts
                                      -2,400,000      -12,100,000 -100,000 -3,500,000  10,000 -810,000 -859,000        
          liquidation of short-term investments
                                                             
          proceeds from sale of equity security
                                                            
          increase in short-term borrowings
                                     -63,900,000 -63,000,000 195,100,000 -7,800,000 8,800,000 100,000 1,300,000  -44,100,000 -1,500,000 -2,100,000 -3,100,000 -32,470,000 -126,747,000 160,117,000         
          cash paid on sale of business or product line
                                    -1,000,000                         
          stock option income tax benefit
                                                 -1,600,000 -1,178,000 -8,441,000 -381,000 -16,000 -280,000 -69,000 -1,140,000 -519,000 -603,000 -1,284,000 -3,879,000 
          proceeds from the sale of businesses
                                                             
          cash assumed in sirona merger
                                             522,300,000             
          proceeds from exercise of stock options
                                                       4,149,000 17,137,000 17,635,000 13,578,000 5,583,000 14,483,000 
          excess tax benefits from stock based compensation
                                                             
          schedule of non-cash investing activities:
                                                             
          merger financed by common stock
                                             6,256,200,000             
          income taxes paid
                                                             
          purchase of company-owned life insurance policies
                                             -1,700,000           -1,577,000 
          cash paid for acquisitions of businesses and equity investments
                                                             
          purchases of short term time deposits
                                                             
          proceeds from redemption of long-term corporate bonds
                                                             
          payments on long-term borrowings
                                                             
          cash assumed in merger
                                                             
          cash and deposits paid for acquisitions of businesses and equity investments, net of cash acquired
                                          -10,700,000                   
          cash received from sale of business or product line
                                              3,600,000 2,400,000             
          cash and deposits paid for acquisitions of businesses, net of cash acquired
                                            -9,100,000                 
          liquidation of short term time deposits
                                                             
          decrease in short-term borrowings
                                                             
          amortization
                                              44,300,000 43,800,000 21,800,000  10,954,000 10,940,000 10,906,000 11,937,000 11,924,000 12,569,000 11,266,000 11,500,000 11,934,000 12,650,000 15,364,000 
          share-based compensation expense
                                              12,000,000 12,600,000 4,800,000  7,670,000 6,935,000 4,895,000 6,543,000 7,572,000 5,786,000 6,004,000 6,589,000 5,434,000 6,807,000 4,222,000 
          excess tax benefits from share-based compensation
                                              -2,500,000 -400,000 -8,400,000  1,178,000 8,441,000 381,000 16,000 280,000 69,000 1,140,000 519,000 603,000 1,284,000 3,879,000 
          equity in net loss from unconsolidated affiliates
                                                  -10,841,000 8,174,000 4,367,000         
          cash paid for acquisitions of businesses, net of cash acquired
                                              -341,400,000 -400,000  5,000     -3,939,000   
          proceeds from redemption of corporate bonds
                                                             
          cash paid for acquisition of noncontrolling interests of consolidated subsidiary
                                                  52,000 -80,452,000 -33,000 -8,960,000   
          equity in net income from unconsolidated affiliates
                                                             
          share based compensation expense
                                                             
          excess tax benefits from share based compensation
                                                             
          equity in loss (earnings) from unconsolidated affiliates
                                                     967,000        
          net change in short-term borrowings
                                                      -102,973,000 64,886,000 -31,661,000 24,317,000 16,133,000 -46,336,000 11,155,000 
          equity income from unconsolidated affiliates
                                                       290,000      
          cash received on derivatives
                                                       864,000 1,673,000     
          cash paid on derivatives
                                                       -2,103,000 -824,000     
          restructuring and other costs - noncash
                                                        -727,000   940,000 1,165,000 
          equity in (earnings) income from unconsolidated affiliates
                                                        83,000     
          payments on settlements of net investment hedges
                                                          -45,765,000   
          interest received on derivatives with an other-than-insignificant financing element
                                                          464,000   
          interest paid on derivatives with an other-than-insignificant financing element
                                                          -306,000   
          net interest expense on derivatives with an other-than-insignificant financing element
                                                           335,000 800,000 
          income taxes payable
                                                           -5,122,000 10,545,000 
          payment on terminated derivative instruments
                                                             
          net interest payments on derivatives with an other-than-insignificant financing element
                                                           -335,000 -800,000